We provide you with 20 years of free, institutional-grade data for ARDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ARDX. Explore the full financial landscape of ARDX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-04 | 1437402 | ARDX | 10-Q | Url |
| 2025-05-01 | 1437402 | ARDX | 10-Q | Url |
| 2025-02-20 | 1437402 | ARDX | 10-K | Url |
| 2024-10-31 | 1437402 | ARDX | 10-Q | Url |
| 2024-08-01 | 1437402 | ARDX | 10-Q | Url |
| 2024-05-02 | 1437402 | ARDX | 10-Q | Url |
| 2024-02-22 | 1437402 | ARDX | 10-K | Url |
| 2023-10-31 | 1437402 | ARDX | 10-Q | Url |
| 2023-08-02 | 1437402 | ARDX | 10-Q | Url |
| 2023-05-03 | 1437402 | ARDX | 10-Q | Url |
| 2023-03-02 | 1437402 | ARDX | 10-K | Url |
| 2022-11-03 | 1437402 | ARDX | 10-Q | Url |
| 2022-08-04 | 1437402 | ARDX | 10-Q | Url |
| 2022-05-05 | 1437402 | ARDX | 10-Q | Url |
| 2022-02-28 | 1437402 | ARDX | 10-K | Url |
| 2021-11-12 | 1437402 | ARDX | 10-Q | Url |
| 2021-08-13 | 1437402 | ARDX | 10-Q | Url |
| 2021-05-06 | 1437402 | ARDX | 10-Q | Url |
| 2021-03-08 | 1437402 | ARDX | 10-K | Url |
| 2020-11-05 | 1437402 | ARDX | 10-Q | Url |
| 2020-08-06 | 1437402 | ARDX | 10-Q | Url |
| 2020-05-07 | 1437402 | ARDX | 10-Q | Url |
| 2020-03-06 | 1437402 | ARDX | 10-K | Url |
| 2019-11-06 | 1437402 | ARDX | 10-Q | Url |
| 2019-08-09 | 1437402 | ARDX | 10-Q | Url |
| 2019-05-07 | 1437402 | ARDX | 10-Q | Url |
| 2019-03-06 | 1437402 | ARDX | 10-K | Url |
| 2018-11-07 | 1437402 | ARDX | 10-Q | Url |
| 2018-08-07 | 1437402 | ARDX | 10-Q | Url |
| 2018-05-08 | 1437402 | ARDX | 10-Q | Url |
| 2018-03-14 | 1437402 | ARDX | 10-K | Url |
| 2017-11-07 | 1437402 | ARDX | 10-Q | Url |
| 2017-08-09 | 1437402 | ARDX | 10-Q | Url |
| 2017-05-05 | 1437402 | ARDX | 10-Q | Url |
| 2017-02-17 | 1437402 | ARDX | 10-K | Url |
| 2016-11-07 | 1437402 | ARDX | 10-Q | Url |
| 2016-08-08 | 1437402 | ARDX | 10-Q | Url |
| 2016-05-09 | 1437402 | ARDX | 10-Q | Url |
| 2016-03-04 | 1437402 | ARDX | 10-K | Url |
| 2015-11-12 | 1437402 | ARDX | 10-Q | Url |
| 2015-08-12 | 1437402 | ARDX | 10-Q | Url |
| 2015-05-12 | 1437402 | ARDX | 10-Q | Url |
| 2015-03-05 | 1437402 | ARDX | 10-K | Url |
| 2014-11-07 | 1437402 | ARDX | 10-Q | Url |
| 2014-08-08 | 1437402 | ARDX | 10-Q | Url |
| 2014-05-19 | 1437402 | ARDX | S-1 | Url |
Ardelyx, Inc(NASDAQ:ARDX) 
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irr...
Website: http://www.ardelyx.com
Founded: 2007
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ARDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.